The central result was that ERAS significantly reduced minor postoperative complications and hospital length of stay, but did not significantly affect mortality rates.
Pathogens · 6 authors, 4 centres
This summary was generated by AI from a single paper. It has not been reviewed by a clinician and is not clinical advice. Verify against the source before acting on it.
The central result was that ERAS significantly reduced minor postoperative complications and hospital length of stay, but did not significantly affect mortality rates.
The cohort included 148 patients, with a subgroup analysis focusing on infected ANP. Statistical analysis showed that the ERAS group had a significantly lower frequency of minor complications requiring conservative or non-general anesthesia surgical treatment (9.5% vs. However, no statistically significant differences were observed between the groups in the incidence of severe complications (grade IIIb) or life-threatening complications like multiple organ failure (MOF). Regression analysis indicated that pre- and post-operative MOF were strong predictors of mortality. Limitations noted include a retrospective design based on medical records, potential selection bias by focusing on patients with infected ANP, and the need for further verification in larger cohorts.